Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
Background To date, no systemic therapy, including immunotherapy, exists to improve clinical outcomes in metastatic uveal melanoma (UM) patients. To understand the role of immune infiltrates in the genesis, metastasis, and response to treatment for UM, we systematically characterized immune profiles...
Saved in:
| Main Authors: | Wei-Lien Wang, Bita Esmaeli, Patrick Hwu, Alexandre Reuben, Michael T Tetzlaff, Jason Roszik, Mariana Petaccia De Macedo, Yong Qin, Kathryn Bollin, Fernando Carapeto, Kevin B Kim, Khalida M Wani, Sujan T Reddy, Michelle D Williams, Dan S Gombos, Alexander J Lazar, Sapna P Patel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000960.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of immune-related risk signature for uveal melanoma
by: Zhaotian Zhang, et al.
Published: (2020-01-01) -
Systematic genomic and translational efficiency studies of uveal melanoma.
by: Chelsea Place Johnson, et al.
Published: (2017-01-01) -
Uveal Melanoma Metastasis to the Thyroid
by: Rokshana R. Thanadar, et al.
Published: (2023-01-01) -
Аngiogenesis in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-10-01) -
Global incidence and prevalence in uveal melanoma
by: Xincen Hou, et al.
Published: (2024-11-01)